FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Smolinski Michael
2. Issuer Name and Ticker or Trading Symbol

Athenex, Inc. [ ATNX ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Scientific Officer
(Last)          (First)          (Middle)

C/O ATHENEX, INC., 1001 MAIN STREET, SUITE 600
3. Date of Earliest Transaction (MM/DD/YYYY)

11/16/2021
(Street)

BUFFALO, NY 14203
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock         5173 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy) $4.55           3/26/2012 3/26/2022 Common Stock 1600  1600 D  
Stock Option (Right to Buy) $4.55           1/2/2015 1/2/2023 Common Stock 4000  4000 D  
Stock Option (Right to Buy) $4.55           12/31/2013 5/13/2023 Common Stock 4200  4200 D  
Stock Option (Right to Buy) $4.55           9/13/2017 9/13/2023 Common Stock 4000  4000 D  
Stock Option (Right to Buy) $5.50           6/30/2015 12/16/2024 Common Stock 6928  6928 D  
Stock Option (Right to Buy) $5.50           12/16/2017 12/16/2024 Common Stock 10000  10000 D  
Stock Option (Right to Buy) $11.00           6/13/2021 6/13/2027 Common Stock 10000  10000 D  
Stock Option (Right to Buy) $17.30            (1)3/27/2028 Common Stock 7500  7500 D  
Stock Option (Right to Buy) $10.26            (2)8/27/2030 Common Stock 24000  24000 D  
Stock Option (Right to Buy) $2.06 11/16/2021  A   25000     (3)11/16/2031 Common Stock 25000 $0.00 25000 D  
Restricted Stock Units  (4)11/16/2021  A   25000     (5) (5)Common Stock 25000 $0.00 25000 D  

Explanation of Responses:
(1) This option vests in four equal annual installments beginning on March 27, 2019.
(2) This option vests in four equal annual installments beginning on August 27, 2021.
(3) This option vests in four equal annual installments beginning on November 16, 2022.
(4) Each restricted stock unit represents a contingent right to receive one share of stock.
(5) The restricted stock units vest in four equal annual installments beginning on November 16, 2022.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Smolinski Michael
C/O ATHENEX, INC.
1001 MAIN STREET, SUITE 600
BUFFALO, NY 14203


Chief Scientific Officer

Signatures
/s/Steven Adams, Attorney-in-Fact1/10/2022
**Signature of Reporting PersonDate

Athenex (NASDAQ:ATNX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Athenex Charts.
Athenex (NASDAQ:ATNX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Athenex Charts.